유전자 편집 완벽 가이드.
★
메뉴
홈 배우기 뉴스
둘러보기 기술들 질환 치료법들 임상시험 기업 과학자들 유전자 연구 기관
의학을 넘어서 농업 윤리 투자 세계 지도
배우기 & 도구 여기서 시작하세요 용어집 A–Z 기술 비교 타임라인 목록 & 순위 AI 에이전트 ★ 저장됨 API
소개 소개 방법론 데이터 출처 편집 방침 문의 면책 조항

안내 보기
유전학이 처음이신가요? 둘러보시는 동안 모든 용어를 쉬운 말로 설명해 드립니다. 도움말이 내장된 동일한 페이지입니다.

전문가 견해
생물학은 이미 알고 계시죠. 내용만, 깔끔하고 간결하게, 추가 설명 없이. 기본 보기입니다.

인터페이스 언어
라이트 모드
Two molecular structures side by side, linked by threads of light

도구

기술 비교

두 가지 또는 세 가지 접근법을 선택하여 정밀도, DNA 절단 방식, 탑재 용량 크기, 전달 방법, 임상 성숙도, 알려진 위험성이 어떻게 다른지 확인해 보세요.

위에서 두 가지 기술을 선택하거나, 아래의 비교 글을 읽어보세요.

서면 비교

사람들이 가장 많이 헷갈리는 개념, 제대로 설명합니다.

the crystal structure of Streptococcus pyogenes Cas9 in complex with sgRNA and its target DNA at 2.5 A ˚ resolution CRISPR-Cas9A protein that can be programmed with a short RNA guide to find one specific sequence in a genome and cut it. Approved A DNA helix with one letter being chemically changed Base EditingChemically converts one DNA letter into another at a chosen position, without cutting both strands of the double helix. Phase III A prime editor writing new letters into a DNA strand Prime EditingWrites a new stretch of DNA sequence directly into a chosen site, using a guide that carries the replacement text with it. Phase I/II A Cas12 enzyme on DNA, scattering fragments CRISPR-Cas12A family of CRISPR nucleases that cut DNA leaving staggered ends, use a different sequence requirement from Cas9, and can be smaller. Phase I/II A Cas13 enzyme cutting a strand of RNA CRISPR-Cas13Targets RNA rather than DNA, so it can silence a gene's message without touching the genome itself. Phase I A tiny Cas14 enzyme bound to a DNA helix Cas14 and miniature Cas systemsUnusually small CRISPR nucleases, roughly a third the size of Cas9, discovered in archaea and bacteriophages. Discovery An enzyme changing a letter on a strand of RNA RNA EditingChanges letters in the RNA message rather than in the DNA, so the effect is real but temporary and the genome is untouched. Phase I/II A DNA helix studded with glowing chemical tags Epigenetic EditingChanges how loudly a gene is expressed by rewriting the chemical marks on and around it, without altering a single letter of DNA sequence. Preclinical A deactivated Cas9 on DNA beaming light to switch a gene on CRISPRa (gene activation)Uses a disabled CRISPR protein to switch a gene up rather than to cut it. Research tool A deactivated Cas9 sitting on a DNA strand, blocking it CRISPRi (gene silencing)Parks a disabled CRISPR protein on a gene to block it from being read, turning it down without changing it. Research tool TALEN protein arms gripping a DNA helix TALENsCustom-built proteins that recognise DNA letter by letter and cut: the technique CRISPR largely displaced, still in clinical use. Phase I/II Zinc finger proteins binding along a DNA helix Zinc Finger NucleasesThe first programmable gene-editing tool to reach patients: small, engineered proteins that grip DNA in three-letter blocks. Phase III A recombinase enzyme swapping DNA segments Recombinases and integrasesEnzymes that cut and rejoin DNA at defined sites, able to insert whole genes rather than edit single letters. Preclinical A transposase moving a DNA segment to a new place TransposasesEnzymes that cut a segment of DNA out of one place and paste it into another: nature's own copy-and-paste. Phase I/II A viral capsid delivering a gene into a cell Gene Therapy (gene addition)Delivers a working copy of a gene into cells without changing the existing genome. It is the older approach that gene editing is often confused with. Approved An RNA-guided complex unwinding a strand of RNA RNA InterferenceUses the cell's own machinery to destroy a specific RNA message, lowering a protein's level without touching DNA. Approved Modular components being assembled on a bench Synthetic BiologyDesigning genetic parts and circuits so that cells perform new functions: the engineering discipline that gene editing serves as a tool. Phase III